CLB Stock Overview
Engages in the cultivation, processing, production, and sale of cannabis in British Columbia, Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Christina Lake Cannabis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.008 |
| 52 Week High | CA$0.17 |
| 52 Week Low | CA$0.005 |
| Beta | -0.90 |
| 1 Month Change | -57.89% |
| 3 Month Change | -75.76% |
| 1 Year Change | -78.08% |
| 3 Year Change | -97.85% |
| 5 Year Change | n/a |
| Change since IPO | -96.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLB | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -0.5% |
| 1Y | -78.1% | -20.1% | 5.2% |
Return vs Industry: CLB underperformed the German Pharmaceuticals industry which returned -20.1% over the past year.
Return vs Market: CLB underperformed the German Market which returned 5.2% over the past year.
Price Volatility
| CLB volatility | |
|---|---|
| CLB Average Weekly Movement | 118.1% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: CLB's share price has been volatile over the past 3 months.
Volatility Over Time: CLB's weekly volatility has increased from 103% to 118% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Mark Aiken | www.christinalakecannabis.com |
Christina Lake Cannabis Corp. engages in the cultivation, processing, production, and sale of cannabis in British Columbia, Canada. It offers cannabis oil, hemp oil, and other hemp and cannabis derived products, as well as distillate oils. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018.
Christina Lake Cannabis Corp. Fundamentals Summary
| CLB fundamental statistics | |
|---|---|
| Market cap | €2.65m |
| Earnings (TTM) | -€2.49m |
| Revenue (TTM) | €8.18m |
0.3x
P/S Ratio-1.1x
P/E RatioIs CLB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLB income statement (TTM) | |
|---|---|
| Revenue | CA$12.13m |
| Cost of Revenue | CA$10.27m |
| Gross Profit | CA$1.86m |
| Other Expenses | CA$5.55m |
| Earnings | -CA$3.69m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.028 |
| Gross Margin | 15.31% |
| Net Profit Margin | -30.45% |
| Debt/Equity Ratio | 51.2% |
How did CLB perform over the long term?
See historical performance and comparison